期刊论文详细信息
Nutrition Journal
Effect of two dietary fibers on satiety and glycemic parameters: a randomized, double-blind, placebo-controlled, exploratory study
Research
Roxanne Kapikian1  Rebecca J Hodge2  Derek J Nunez2  David M Savastano3  Ann Walker4 
[1] Biostatistics, Consumer Healthcare, GlaxoSmithKline, Parsippany, NJ, USA;Discovery Medicine, GlaxoSmithKline, Five Moore Drive, MS N2-3208, 27709, Research Triangle Park, NC, USA;Medical Affairs, Consumer Healthcare, GlaxoSmithKline, Parsippany, NJ, USA;Statistics and Programming, GlaxoSmithKline, Research Triangle Park, NC, USA;
关键词: OFS;    Pectin;    Dietary fibers;    Glucose;    Satiety;   
DOI  :  10.1186/1475-2891-13-45
 received in 2014-01-21, accepted in 2014-05-12,  发布年份 2014
来源: Springer
PDF
【 摘 要 】

BackgroundDietary carbohydrates may affect metabolic and physiologic parameters. The present study evaluated whether a combination of two dietary fibers, oligofructose (OFS) and pectin (P), altered satiety and glycemic parameters. The primary objective of this study was to determine whether dietary supplementation for 3 weeks with OFS + P would produce a greater reduction in energy intake of an ad libitum test meal compared to control.MethodsThis was a single center, randomized, double-blind, placebo-controlled, parallel group study in overweight and obese, otherwise healthy, subjects (N = 96). There were two OFS + P treatment groups: high-dose (30 g/d), low-dose (15 g/d), and a control group (maltodextrin 15 g/d). Energy intake, appetite measures based on Satiety Labeled Intensity Magnitude (SLIM) scale, fasting and post-prandial glucose, and insulin levels and body weight were measured at baseline and at the end of 3 weeks. Adverse events and gastrointestinal tolerability of the treatments were also assessed.ResultsAn analysis of covariance (ANCOVA) performed on the primary endpoint change from baseline in energy intake, showed no statistically significant difference in energy intake among the three treatment groups (p = 0.5387). The LS mean changes (SE) in energy intake from baseline to week 3 were −58.3 (42.4) kilocalories (kcal) for the high dose group, −74.2 (43.6) kcal for the low dose group, and −9.0 (42.9) kcal for the control group. For the pairwise comparisons of OFS + P doses and control, confidence intervals were constructed around the difference in LS mean changes. All study products were generally well tolerated.ConclusionThere was a directional benefit in ad libitum energy intake for both OFS + P doses compared to control, with a greater reduction in kilocalories in the low dose comparison, but the reductions were not significant. Further studies are warranted.Clinical trial registrationGSK Clinical Study Register # W7781293

【 授权许可】

Unknown   
© Savastano et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

【 预 览 】
附件列表
Files Size Format View
RO202311102482698ZK.pdf 1318KB PDF download
【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  文献评价指标  
  下载次数:29次 浏览次数:2次